RNAC - Cartesian Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.50
DETAILS
HIGH:
$25.00
LOW:
$16.00
MEDIAN:
$20.50
CONSENSUS:
$20.50
UPSIDE:
115.56%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 2.8 | 38.9 | 26.0 | 110.8 | 85.1 | 16.6 | 6.7 | 0.9 | 0.2 | 8.1 | 6.0 | 3.0 |
| Cost of Revenue | 0 | 0 | 0 | 2.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 2.8 | 38.9 | 26.0 | 108.7 | 85.1 | 16.6 | 6.7 | 0.9 | 0.2 | 8.1 | 6.0 | 3.0 |
| Operating Expenses | ||||||||||||
| R&D Expenses | 58.0 | 45.1 | 71.3 | 72.4 | 68.7 | 54.5 | 42.7 | 47.7 | 45.2 | 29.7 | 23.0 | 10.5 |
| SG&A Expenses | 31.5 | 30.1 | 40.5 | 23.9 | 20.9 | 18.9 | 16.4 | 17.3 | 18.1 | 12.2 | 7.3 | 8.0 |
| Other Expenses | 0 | 7.6 | 0.7 | (2.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 89.5 | 82.8 | 112.4 | 94.2 | 89.7 | 73.4 | 59.1 | 65.0 | 63.2 | 42.0 | 30.3 | 18.4 |
| Operating Income | ||||||||||||
| Operating Income | (86.7) | (43.9) | (86.4) | 14.5 | (4.6) | (56.8) | (52.5) | (65.0) | (63.8) | (34.7) | (25.3) | (15.4) |
| Interest Expense | 0 | 0 | 2.8 | 3.0 | 2.8 | 1.6 | 1.5 | 1.5 | 1.2 | 1.3 | 0.9 | 0.6 |
| Interest Income | 6.6 | 7.4 | 5.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||
| EBITDA | (139.5) | (76.0) | (235.0) | 39.8 | (5.2) | (65.6) | (51.8) | (62.9) | (63.4) | (34.2) | (23.2) | (11.5) |
| EBIT | (139.5) | (77.1) | (235.9) | 37.8 | (6.9) | (67.3) | (53.8) | (63.8) | (64.1) | (35.0) | (24.2) | (12.3) |
| Income Before Tax | (139.5) | (77.1) | (238.7) | 34.8 | (9.7) | (68.9) | (55.4) | (65.3) | (65.3) | (36.2) | (25.2) | (12.9) |
| Income Tax Expense | (9.2) | 0.3 | (19) | (0.6) | 16.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (130.3) | (77.4) | (219.7) | 35.4 | (25.7) | (68.9) | (55.4) | (65.3) | (65.3) | (36.2) | (25.2) | (12.9) |
| Per Share Data | ||||||||||||
| EPS (Basic) | -5.02 | -2.99 | -49.76 | 7.33 | -6.74 | -20.42 | -36.46 | -87.55 | -95.94 | -103.52 | -75.79 | -38.17 |
| EPS (Diluted) | -5.02 | -3.29 | -49.76 | 3.00 | -6.60 | -20.42 | -36.46 | -87.55 | -95.94 | -103.52 | -75.79 | -38.17 |
| Shares Outstanding | 26.0 | 25.9 | 5.2 | 4.0 | 3.2 | 2.8 | 1.3 | 0.6 | 0.6 | 0.3 | 0.4 | 0.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||
| Cash & Cash Equivalents | 125.1 | 212.6 | 76.9 | 106.4 | 114.1 | 138.7 | 90.2 | 37.4 | 70.7 | 58.7 | 32.3 | 16.6 |
| Short-Term Investments | 0 | 0 | 0 | 28.2 | 14.0 | 0 | 0 | 0 | 25.9 | 25.5 | 4.1 | 0 |
| Net Receivables | 1.1 | 0.9 | 8.9 | 9.9 | 9.9 | 7.2 | 5 | 0 | 0.1 | 0.2 | 0.8 | 0.7 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.0) | 0 | 0 | 0 |
| Other Current Assets | 3.0 | 3.1 | 5.0 | 3.7 | 0 | 0 | 0 | 0 | 2.0 | 0.1 | 0.1 | 1.2 |
| Total Current Assets | 129.3 | 216.6 | 90.7 | 148.1 | 144.4 | 151.3 | 96.7 | 42.1 | 98.7 | 86.8 | 38.9 | 19.1 |
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment | 17.8 | 15.4 | 12.2 | 14.4 | 12.0 | 12.3 | 1.5 | 2.1 | 2.1 | 2.0 | 2.0 | 2.0 |
| Goodwill | 48.2 | 48.2 | 48.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 150.6 | 150.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.7 | 2 | 2 | 2 | 2 | 0 | 1.4 | 0.3 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 99.5 | 2.2 | 1.4 | 1.3 | 1.5 | 1.7 | 0 | 0 | 0.3 | 0.4 | 1.9 | 1.1 |
| Total Non-Current Assets | 167.1 | 218.4 | 214.3 | 17.7 | 15.4 | 14.1 | 2.9 | 2.4 | 2.4 | 2.5 | 3.9 | 3.1 |
| Total Assets | 296.4 | 435.0 | 305.1 | 165.9 | 159.9 | 165.4 | 99.6 | 44.5 | 101.1 | 89.3 | 42.8 | 22.2 |
| Current Liabilities | ||||||||||||
| Account Payables | 1.3 | 0.3 | 3.1 | 0.3 | 0.2 | 0.4 | 0.5 | 1.1 | 1.6 | 3.9 | 2.2 | 0.4 |
| Short-Term Debt | 4.2 | 0 | 0 | 8.5 | 6.0 | 0 | 18.9 | 21.4 | 0 | 4.1 | 0 | 2.6 |
| Deferred Revenue | 0 | 0 | 2.3 | 0.6 | 53.9 | 72.0 | 1.7 | 1.0 | 0.8 | 1.8 | 1.3 | 3.0 |
| Other Current Liabilities | 9.5 | 19.8 | 56.2 | 0 | 0 | 0 | 0 | 9.2 | 0.1 | 0.0 | 0.8 | 2.6 |
| Total Current Liabilities | 14.9 | 23.0 | 68.2 | 25.1 | 72.3 | 81.5 | 34.9 | 35.1 | 11.0 | 13.7 | 7.3 | 9.2 |
| Non-Current Liabilities | ||||||||||||
| Long-Term Debt | 0 | 0 | 0 | 17.8 | 19.7 | 24.8 | 0 | 0 | 21.0 | 8.0 | 11.9 | 4.8 |
| Deferred Tax Liabilities | 6.9 | 16.1 | 322.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 392.2 | 391.6 | 342.6 | 19.1 | 25.4 | 28.7 | 41.5 | 0.9 | 1.4 | 0.2 | 137.9 | 94.6 |
| Total Non-Current Liabilities | 407.7 | 418.8 | 677.0 | 47.0 | 65.1 | 101.9 | 56.2 | 14.8 | 38.3 | 20.6 | 152.0 | 100.8 |
| Total Liabilities | 422.7 | 441.8 | 745.2 | 72.1 | 137.4 | 183.4 | 91.2 | 49.9 | 49.3 | 34.3 | 159.3 | 110.0 |
| Stockholders' Equity | ||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (822.4) | (692.1) | (614.6) | (394.9) | (430.3) | (404.6) | (335.8) | (280.4) | (216.9) | (151.6) | (111.5) | (83.9) |
| Accumulated Other Comprehensive Income | (4.6) | (4.6) | (4.6) | (4.6) | (4.6) | (4.6) | (4.5) | (4.6) | (4.4) | (4.5) | (5.0) | (3.9) |
| Total Stockholders' Equity | (126.2) | (6.8) | (440.2) | 93.8 | 22.5 | (18.0) | 8.4 | (5.4) | 51.8 | 55.0 | (116.5) | (87.8) |
| Total Liabilities & Equity | 296.4 | 435.0 | 305.1 | 165.9 | 159.9 | 165.4 | 99.6 | 44.5 | 101.1 | 89.3 | 42.8 | 22.2 |
| Debt Metrics | ||||||||||||
| Total Debt | 12.7 | 14.0 | 11.0 | 37.9 | 35.3 | 35.3 | 19.3 | 21.4 | 21.0 | 12.0 | 11.9 | 7.4 |
| Net Debt | (112.5) | (198.6) | (66.0) | (68.5) | (78.8) | (103.3) | (70.9) | (16.0) | (49.7) | (46.6) | (20.5) | (9.2) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | (130.3) | (77.4) | (219.7) | 35.4 | (25.7) | (68.9) | (55.4) | (65.3) | (65.3) | (36.2) | (25.2) | (12.9) |
| Depreciation & Amortization | 3.0 | 1.2 | 0.8 | 1.3 | 1.3 | 0.7 | 2.0 | 1.0 | 0.8 | 0.8 | 1.0 | 0.9 |
| Stock-Based Compensation | 10.5 | 6.6 | 22.5 | 11.2 | 7.7 | 5.4 | 0 | 0 | 0 | 0 | 0 | 1.2 |
| Change in Working Capital | (8.1) | (5.8) | 5.0 | (60.4) | (48.2) | 85.0 | (4.5) | (0.8) | 7.1 | 13.2 | 0.4 | (2.1) |
| Other Non-Cash Items | 60.1 | 51.5 | 159.2 | 2.3 | 2.1 | 12.6 | 6.4 | 8.4 | 9.1 | 0.8 | 2.8 | 0.2 |
| Operating Cash Flow | (73.9) | (23.7) | (51.2) | (31.6) | (60.4) | 34.9 | (51.4) | (59.2) | (52.0) | (19.7) | (22.5) | (12.7) |
| Investing Activities | ||||||||||||
| Capital Expenditure | (5.5) | (9.1) | (0.2) | (1.2) | (1.1) | (0.8) | (0.0) | (0.9) | (0.7) | (0.6) | (1.2) | (0.2) |
| Acquisitions | 0 | 0.4 | 6.6 | 0 | 0 | 0 | 0.1 | 0.1 | 0.0 | 0.0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (33.5) | (32.5) | 0 | (18.2) | (15.6) | (61.5) | (28.4) | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 28.3 | 19.7 | 16.4 | 0 | 18.3 | 41.7 | 60.2 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 6.9 | (3.5) | 0 |
| Investing Cash Flow | (5.5) | (8.7) | 34.6 | (15.0) | (17.1) | (0.7) | 0.2 | 25.3 | (2.1) | (22.1) | (4.7) | (0.2) |
| Financing Activities | ||||||||||||
| Net Debt Issuance | 0 | 0 | (27.5) | 0 | 0 | 5.4 | (2.8) | 0 | 8.0 | 0 | 11.4 | 4.5 |
| Stock Repurchased | 0 | 0 | (6.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (7.8) | 4.0 | 0.2 | 0.2 | 0.9 | (3.4) | 70.2 | 0.7 | 0.9 | (4.0) | (0.3) | 0.1 |
| Financing Cash Flow | (8.1) | 168.4 | (13.1) | 39.2 | 52.9 | 14.4 | 105.0 | 0.7 | 66.0 | 67.7 | 43.9 | 24.8 |
| Cash Position | ||||||||||||
| Net Change in Cash | (87.4) | 136.0 | (29.8) | (7.4) | (24.6) | 48.5 | 52.8 | (33.3) | 12.0 | 25.9 | 16.8 | 8.5 |
| Cash at Beginning | 214.3 | 78.3 | 108.0 | 115.4 | 140.1 | 91.6 | 37.4 | 70.7 | 58.7 | 32.9 | 15.7 | 8.1 |
| Cash at End | 126.9 | 214.3 | 78.3 | 108.0 | 115.4 | 140.1 | 90.2 | 37.4 | 70.7 | 58.7 | 32.5 | 16.6 |
| Free Cash Flow | (79.4) | (32.8) | (51.4) | (32.8) | (61.5) | 34.1 | (51.5) | (60.0) | (52.8) | (20.3) | (23.6) | (12.9) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 2.8 | 38.9 | 26.0 | 110.8 | 85.1 | 16.6 | 6.7 | 0.9 | 0.2 | 8.1 | 6.0 | 3.0 |
| Gross Profit | 2.8 | 38.9 | 26.0 | 108.7 | 85.1 | 16.6 | 6.7 | 0.9 | 0.2 | 8.1 | 6.0 | 3.0 |
| Operating Income | (86.7) | (43.9) | (86.4) | 14.5 | (4.6) | (56.8) | (52.5) | (65.0) | (63.8) | (34.7) | (25.3) | (15.4) |
| Net Income | (130.3) | (77.4) | (219.7) | 35.4 | (25.7) | (68.9) | (55.4) | (65.3) | (65.3) | (36.2) | (25.2) | (12.9) |
| EPS (Diluted) | -5.02 | -3.29 | -49.76 | 3.00 | -6.60 | -20.42 | -36.46 | -87.55 | -95.94 | -103.52 | -75.79 | -38.17 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 125.1 | 212.6 | 76.9 | 106.4 | 114.1 | 138.7 | 90.2 | 37.4 | 70.7 | 58.7 | 32.3 | 16.6 |
| Total Assets | 296.4 | 435.0 | 305.1 | 165.9 | 159.9 | 165.4 | 99.6 | 44.5 | 101.1 | 89.3 | 42.8 | 22.2 |
| Total Debt | 12.7 | 14.0 | 11.0 | 37.9 | 35.3 | 35.3 | 19.3 | 21.4 | 21.0 | 12.0 | 11.9 | 7.4 |
| Stockholders' Equity | (126.2) | (6.8) | (440.2) | 93.8 | 22.5 | (18.0) | 8.4 | (5.4) | 51.8 | 55.0 | (116.5) | (87.8) |
| Cash Flow | ||||||||||||
| Operating Cash Flow | (73.9) | (23.7) | (51.2) | (31.6) | (60.4) | 34.9 | (51.4) | (59.2) | (52.0) | (19.7) | (22.5) | (12.7) |
| Capital Expenditure | (5.5) | (9.1) | (0.2) | (1.2) | (1.1) | (0.8) | (0.0) | (0.9) | (0.7) | (0.6) | (1.2) | (0.2) |
| Free Cash Flow | (79.4) | (32.8) | (51.4) | (32.8) | (61.5) | 34.1 | (51.5) | (60.0) | (52.8) | (20.3) | (23.6) | (12.9) |